Share This Author
M AN US CR IP T AC CE PT ED ACCEPTED MANUSCRIPT
The paucity of data regarding the natural history of neurodevelopment in infants with TSC and the lack of a gold standard for neurodevelopmental evaluation presents a significant challenge for clinicians.
A systematic review of the role of intrapartum hypoxia-ischemia in the causation of neonatal encephalopathy.
Neuroprotective and disease-modifying effects of the ketogenic diet
There is evidence that the ketogenic diet can provide symptomatic and disease-modifying activity in a broad range of neurodegenerative disorders including Alzheimer's disease and Parkinson's disease, and may also be protective in traumatic brain injury and stroke.
The ketogenic diet: Uses in epilepsy and other neurologic illnesses
A growing body of literature suggests the ketogenic diet may be beneficial in certain neurodegenerative diseases, including Alzheimer disease, Parkinson’s disease, and amyotrophic lateral sclerosis, in which it appears to be neuroprotective.
The neuropharmacology of the ketogenic diet.
Clinical Aspects of the Ketogenic Diet
This critical analysis of the ketogenic diet should provide the impetus for further clinical and basic research into the diet's application and mechanisms of action.
Ketone bodies in epilepsy
J. Neurochem. (2012) 121, 28–35.
A Randomized Trial of Erythropoietin for Neuroprotection in Preterm Infants.
High-dose erythropoietin treatment administered to extremely preterm infants from 24 hours after birth through 32 weeks of postmenstrual age did not result in a lower risk of severe neurodevelopmental impairment or death at 2 years of age.
High-dose oral prednisolone for infantile spasms: An effective and less expensive alternative to ACTH